Dopamine and Parkinson's disease: is the killer in the house?

被引:15
|
作者
Chesselet, MF [1 ]
机构
[1] Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, Los Angeles, CA 90024 USA
关键词
D O I
10.1038/sj.mp.4001289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:369 / 370
页数:2
相关论文
共 50 条
  • [31] The dopamine transporter: Importance in Parkinson's disease
    Nutt, JG
    Carter, JH
    Sexton, GJ
    ANNALS OF NEUROLOGY, 2004, 55 (06) : 766 - 773
  • [32] Dopamine agonists in the treatment of Parkinson's disease
    Bracco, F
    Delibori, D
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 201 - 207
  • [33] Dopamine receptor agonists for Parkinson's disease
    Blandini, Fabio
    Armentero, Marie-Therese
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (03) : 387 - 410
  • [34] Dopamine neurotransmission, Parkinson’s disease and SPET
    D.C. Costa
    A.J. Lees
    European Journal of Nuclear Medicine and Molecular Imaging, 2002, 29 : 163 - 163
  • [35] Role of dopamine in the pathophysiology of Parkinson's disease
    Zhou, Zhi Dong
    Yi, Ling Xiao
    Wang, Dennis Qing
    Lim, Tit Meng
    Tan, Eng King
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [36] Role of dopamine in the pathophysiology of Parkinson’s disease
    Zhi Dong Zhou
    Ling Xiao Yi
    Dennis Qing Wang
    Tit Meng Lim
    Eng King Tan
    Translational Neurodegeneration, 12
  • [37] Nutrition and Dopamine Metabolism in Parkinson's Disease
    Leader, L.
    MOVEMENT DISORDERS, 2010, 25 : S605 - S605
  • [38] The role of natural killer cells in Parkinson's disease
    Earls, Rachael H.
    Lee, Jae-Kyung
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (09): : 1517 - 1525
  • [39] The role of natural killer cells in Parkinson’s disease
    Rachael H. Earls
    Jae-Kyung Lee
    Experimental & Molecular Medicine, 2020, 52 : 1517 - 1525
  • [40] Creativity induced by dopamine agonists in Parkinson's disease
    Batir, A.
    Lhommee, E.
    Ardouin, C.
    Fraix, V.
    Seigneuret, E.
    Chabardes, S.
    Benabid, A. -L.
    Pollak, P.
    Krack, P.
    MOVEMENT DISORDERS, 2009, 24 : S234 - S234